Follow-Up Care for Children Prescribed ADHD Medication (ADD) - Continuation and Maintenance Phase

The percentage of children newly prescribed attention-deficit/hyperactivity disorder (ADHD) medication who had at least three follow-up care visits within a 300-day (10 month) period, one of which was within 30 days of when the first ADHD medication was dispensed. 


• Continuation and Maintenance (C&M) Phase. The percentage of members 6–12 years of age with a prescription dispensed for ADHD medication, who remained on the medication for at least 210 days and who, in addition to the visit in the initiation phase, had at least two follow-up visits with a practitioner within 270 days (9 months) after the initiation phase ended.

Measure Identifier: HEDIS_ADD-E.CON

Customize
View: Totals By Submitter      Trend type: Line Bar       Hide confidence intervals       Hide labels       Hide graphs       Hide tables
Print | PDF

Please see Report Details below for more information on selected subgroups, organizations, and aggregation.

Tables

Data


HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA).

Report Details

Generated on Sep 06 2026 at 04:21
Measures: Follow-Up Care for Children Prescribed ADHD Medication (ADD) - Continuation and Maintenance Phase
Max Time Periods: 16
Organizations: All (aggregated)

Citation: NH Department of Health and Human Services. Bureau of Program Quality. Report generated on Sep 06 2026 at 04:21. [http://medicaidquality.nh.gov]

Disclaimer: While the NH Department of Health and Human Services - Bureau of Program Quality makes every effort to post accurate and reliable information, it does not guarantee or warrant that the information on this website is complete, accurate or up-to-date and assumes no responsibility for the use or application of any posted material.